GlassScriptPhysician profile
Kendra Danielle Armer
NPI 1447905989
$1,599.81
in general payments reported to CMS, 2019-2025
22 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $352 · 2023: $553 · 2024: $288 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,095 · Education: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.74 |
| Education | $153.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $271.37 | 2022-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $165.19 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $161.68 | 2023 | Erleada |
| Astellas Pharma US INC | $153.05 | 2023-2024 | |
| Axonics, INC. | $101.15 | 2022-2023 | Axonics |
| Coloplast Corp | $99.75 | 2022-2025 | Speedicath |
| Dendreon Pharmaceuticals LLC | $93.85 | 2022-2025 | Provenge |
| Endo Pharmaceuticals INC. | $62.20 | 2022-2024 | Xiaflex, Aveed |
| Angiodynamics, INC. | $54.52 | 2025 | Nanoknife |
| Tolmar, INC. | $53.16 | 2025 | Jatenzo, Eligard |
| 180 Medical, INC. | $51.70 | 2023-2024 | Gentlecath Glide |
| Endo USA, INC. | $48.51 | 2024-2025 | Xiaflex |
| Urovant Sciences INC | $45.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $42.50 | 2023 | Lynparza |
| Ferring Pharmaceuticals INC. | $42.47 | 2024 | Adstiladrin |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $37.65 | 2023 | |
| Procept Biorobotics Corporation | $33.19 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $21.38 | 2025 | |
| Antares Pharma, INC. | $17.46 | 2023 | Nocdurna, Xyosted, Tlando |
| Abc Home Medical Supply, INC. | $17.00 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $14.82 | 2022 | |
| Hollister Incorporated | $12.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Armer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.